You can now read 10 articles each month for free on BostonGlobe.com.

The Boston Globe

Business

Around the Region

Biotech group opposes rezoning

The state’s largest biotechnology trade group sent a letter­ to Cambridge city officials on Monday to oppose a proposal by neighborhood activists that would change zoning in an area around Central Square, potentially blocking large-scale development or expansion plans for life sciences­ companies.

In the letter, sent to the chairmen of the City Council’s ordinance committee and the Planning Board, Robert K. Coughlin, president of the Massachusetts Biotechnology Council, noted the city is home to more than 110 life sciences companies that were drawn to nearby research universities and hospitals.

Loading comments...

You have reached the limit of 10 free articles a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than $1 a week